Serostim
Payments companies reported to CMS as associated with Serostim. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Serostim, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Serostim
These are the largest totals companies reported as associated with Serostim. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Shalit | Seattle, WA | Internal Medicine | $105,586.25 |
| Joseph Gathe | Houston, TX | Infectious Disease | $64,822.56 |
| Noah Lee | Oakland Park, FL | Family Medicine | $56,431.43 |
| Douglas Cunningham | Phoenix, AZ | Family Medicine | $55,505.42 |
| Ricky Hsu | New York, NY | Internal Medicine | $42,411.29 |
| Jihad Slim | Newark, NJ | Infectious Disease | $33,152.66 |
| Adam Zweig | San Diego, CA | Internal Medicine | $28,667.04 |
| Danny Deckard | Dallas, TX | Medical | $8,130.80 |
| Maurice Brownlee | Chicago, IL | Psychiatric/Mental Health (Nurse Practitioner) | $7,524.05 |
| Virginia Cafaro | San Francisco, CA | Internal Medicine | $7,305.03 |
Prescribed Serostim?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.